OTHER CURRENT LIABILITIES (Tables)

3 Months Ended

Mar. 31, 2014

Noncontrolling Interest [Abstract]

Schedule of other current liabilities

Other current liabilities consist of the following:

	March 31, 2014		December 31, 2013
Accrued payroll and commission costs	$	444,749	$	941,313
Accrued vacation costs		387,908		256,920
Allowance for wholesale distributor fees		290,780		306,303
Accrued clinical research		205,000		—
Accrued offering fees		165,000		—
Accrued royalties		174,600		52,188
Accrued clinical trial costs		93,215		129,208
Allowance for coupons and returns		150,180		126,233
Accrued rent		71,257		—
Accrued legal and accounting expense		60,000		224,550
Other accrued expenses(1)		229,284		177,900
Accrued financing costs		—		850,000
Accrued lab research		—		536,574
TOTAL OTHER CURRENT LIABILITIES	$	2,271,973	$	3,601,189

______________

⁽¹⁾ In June 2008, we declared and paid a special dividend of $0.40 per share of our common stock to all stockholders of record as of June 10, 2008, of which $41,359 remained unclaimed by certain shareholders at March 31, 2014 and December 31, 2013.